# Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children

> **NCT03893097** · PHASE3 · COMPLETED · sponsor: **Institute of Tropical Medicine, Belgium** · enrollment: 726 (actual)

## Conditions studied

- Schistosoma Haematobium
- Schistosoma Mansoni

## Interventions

- **DRUG:** Praziquantel
- **DRUG:** Artesunate + Mefloquine

## Key facts

- **NCT ID:** NCT03893097
- **Lead sponsor:** Institute of Tropical Medicine, Belgium
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-14
- **Primary completion:** 2021-03-04
- **Final completion:** 2021-03-04
- **Target enrollment:** 726 (ACTUAL)
- **Last updated:** 2021-04-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03893097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03893097, "Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT03893097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*